πŸ‡ΊπŸ‡Έ FDA
Patent

US 9636412

Conjugates of an anti-TNF-alpha antibody

granted A61KA61K2039/6093A61K39/3955

Quick answer

US patent 9636412 (Conjugates of an anti-TNF-alpha antibody) held by Nektar Therapeutics expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/6093, A61K39/3955, A61K39/44, A61K47/60